Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
AT&T
T
|
+$838M |
| 2 |
Booking.com
BKNG
|
+$347M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$337M |
| 4 |
Boeing
BA
|
+$300M |
| 5 |
Walmart
WMT
|
+$294M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$580M |
| 2 |
NVIDIA
NVDA
|
+$564M |
| 3 |
iShares MBS ETF
MBB
|
+$460M |
| 4 |
T-Mobile US
TMUS
|
+$447M |
| 5 |
Apple
AAPL
|
+$431M |
Sector Composition
| 1 | Technology | 14.12% |
| 2 | Healthcare | 13.93% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 10.51% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
First Trust Enhanced Short Maturity ETF
FTSM
$6.17B
| $18.7M | ﹤0.01% |
311,794
-42,507
| -12% | -$2.55M |
|
902
Franco-Nevada
FNV
$39B
| $18.7M | ﹤0.01% |
128,703
+100,799
| +361% | +$14.6M |
|
903
Novo Nordisk
NVO
$241B
| $18.6M | ﹤0.01% |
444,958
-8,970
| -2% | -$376K |
|
904
Diageo
DEO
$57.6B
| $18.6M | ﹤0.01% |
97,006
-67,021
| -41% | -$12.8M |
|
905
Stitch Fix
SFIX
$759M
| $18.6M | ﹤0.01% |
308,305
+69,778
| +29% | +$4.21M |
|
906
Moelis & Co
MC
$5.62B
| $18.5M | ﹤0.01% |
325,304
+75,221
| +30% | +$4.28M |
|
|
KRON
907
DELISTED
Kronos Bio
KRON
| $18.4M | ﹤0.01% |
767,608
-81,440
| -10% | -$1.95M |
|
|
AUTL
908
Autolus Therapeutics
AUTL
$383M
| $18.3M | ﹤0.01% |
2,762,754
+2,721,085
| +6,530% | +$18.1M |
|
909
Kennametal
KMT
$1.6B
| $18.3M | ﹤0.01% |
508,279
+490,871
| +2,820% | +$17.6M |
|
910
Dollar Tree
DLTR
$20.3B
| $18.2M | ﹤0.01% |
+183,385
| New | +$18.2M |
|
911
Yeti Holdings
YETI
$2.98B
| $18.2M | ﹤0.01% |
198,646
+15,325
| +8% | +$1.41M |
|
912
Manulife Financial
MFC
$54B
| $18.2M | ﹤0.01% |
925,570
+707,525
| +324% | +$13.9M |
|
913
Hancock Whitney
HWC
$5.37B
| $18.2M | ﹤0.01% |
409,230
-592,761
| -59% | -$26.3M |
|
914
Schwab US TIPS ETF
SCHP
$14.1B
| $18.2M | ﹤0.01% |
581,730
+438,314
| +306% | +$13.7M |
|
915
DoorDash
DASH
$111B
| $18.2M | ﹤0.01% |
101,809
+91,426
| +881% | +$16.3M |
|
916
InMode
INMD
$970M
| $18.1M | ﹤0.01% |
382,314
-49,684
| -12% | -$2.35M |
|
917
Protagonist Therapeutics
PTGX
$3.71B
| $18.1M | ﹤0.01% |
403,208
+204,990
| +103% | +$9.2M |
|
918
Universal Health Services
UHS
$12.1B
| $18M | ﹤0.01% |
123,106
-3,549
| -3% | -$520K |
|
|
HCNEU
919
DELISTED
Jaws Hurricane Acquisition Corp. Unit
HCNEU
| $18M | ﹤0.01% |
+1,789,564
| New | +$18M |
|
920
JPMorgan Ultra-Short Income ETF
JPST
$33.5B
| $17.9M | ﹤0.01% |
351,892
+218,660
| +164% | +$11.1M |
|
921
Arrowhead Research
ARWR
$4.11B
| $17.8M | ﹤0.01% |
214,988
-192,675
| -47% | -$16M |
|
|
ASZ.U
922
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
| $17.8M | ﹤0.01% |
1,767,801
-1,246,326
| -41% | -$12.5M |
|
923
Invesco CurrencyShares Japanese Yen Trust
FXY
$563M
| $17.8M | ﹤0.01% |
209,869
+49,702
| +31% | +$4.21M |
|
|
FRC
924
DELISTED
First Republic Bank
FRC
| $17.7M | ﹤0.01% |
94,747
+89,979
| +1,887% | +$16.8M |
|
925
Scotiabank
BNS
$79.8B
| $17.7M | ﹤0.01% |
272,499
+172,268
| +172% | +$11.2M |
|